Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL.

Statins reduce coronary and cerebrovascular events in primary and secondary prevention. More intensive statin therapy compared with moderate-intensity statin therapy decreases risk even further [(1)][1]. Therefore, the 2013 American College of Cardiology/American Heart Association (ACC/AHA)